Why
Why invest in MedTech?
What sets us apart
HIGH MULTIPLES, FEW LOSSES, NO UNICORNS
UNIQUE COMMERCIALISATION APPROACH
WE INVEST IN PEOPLE
What we stand for
Fund
We believe and invest in the next generation of life saving Medical technologies and Digital Health Applications to ensure future health and making lifes easier. We facilitate the creation of new opportunities and set new standards of care.
What we look for
Our focus is the convergence of Digital, Healthcare and Technology – MedTech, Digital Health and Digital Applications.
Academically routed start-ups typically face a lack in three major areas.
We provide comprehensive operational support for unexperienced founders.
Corporate Governance
While we do not engage ourselves in the day-to-day operations, we provide strategic advice and assistance with:
We cover every single aspect of the global healthcare industry.
Market Knowledge
We offer direct access to the complete bandwidth of players in the whole healthcare ecosystem.
Network
We have a clear definition of the investments we make.
Investment Strategy Summary
Target Volume
€ 50M
Target Geographics
Europe (incl. Israel)
Target Sectors
MedTech, Digital Health, Digital Health Applications
Target Investments
€ 500k – 3M per target
Target Stages
Early stage & before (Pre Seed)
We back visionary teams working hard to improve patients' lives.
Portfolio
By entrepreneurs for enterprising professionals.
Team
Broad experience (2 decades) in various executive positions in international large-scale enterprises in HC (J+J, KC, 3M, GOJO etc.). Over 15 years c-level positions and shareholder in SME. Inventor of patented technologies. Managing Partner at the market leader in management due diligence for European private equity companies. Profound know-how and reliable network in Healthcare. Successful Angel investor in several HC ventures.
Founder of various companies since the early 90ies with a focus on medical technology. Since 2017 CEO of Invitrocue Europe and board member of Invitrocue Singapore, a company in the field of oncology diagnostic. Broad VC experience and invested in numerous companies. PhD thesis in int. expansion of US high-tech companies in Europe.
Medical Specialist for Pharmaceutical Medicine and MBA ETH Zurich/Boston University. Marketing and clinical drug development at Ciba-Geigy Germany and Schering-Plough US. Managing Partner at Capman Venture Capital. Executive positions and management consulting in Health Care and Life Sciences for more than 30 years.
Founder of Saint Clair Advisory, Carl supports Investors, Family Offices and Venture Funds in Investment and Fundraising Strategy, drawing from his academic research on Soft Due Diligence, a systematic evaluation process for intangible success factors. Carl promotes the positioning of Emerging and First-Time Funds as a rational target for capital allocation and facilitates their exposure to Limited Partners.
Medical Specialist for Orthopaedics and Trauma Surgery. After completing his MBA studies at INSEAD and consulting at Bain & Company and Advisors in Healthcare he returned to TU Munich founded the task force digitalization and habilitated in 2018. Co-chairman of the task force digitalization at DGOU and Chairman of the jury of Inventors for Health Award (Stiftung Charité).
Entrepreneur, medical doctor, data scientist, being recognized as a leading expert at the intersection of artificial intelligence, data, digitization, and healthcare. After medical studies at LMU (Munich) and Harvard (Boston), earned an MBA from MBS and a Master's degree in Data Science at LMU. Leader in multiple initiatives & companies in the field of Health AI, developing next-generation diagnostic solutions to improve patient care and enable precision medicine – received the Eugen-Münch Price for healthcare innovation in 2019.
Get in touch
Contact
Headquarter
MedTech Entrepreneurs Management GmbH
Location
Hildegardstr. 9, 80539 Munich
Phone
+49 89 122 24 95 -0
Email
post@mte.vc